• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Cipla Ltd.
    16 May 2024
    1589.40
    0.58%
    Cipla promoters sell 2.53% stake for Rs 2,751 crore
    Cipla promoters sell 2.53% stake for Rs 2,751 crore
    Economic Times
    "Post transaction, the entire promoter group, including persons acting in concert, continues to hold 31.67% in the company and remains committed to the future of Cipla," the company said in a statement.
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. is trading above all available SMAs
    Cipla promoters sold shares for reasons including philanthropy
    Business Line | 15 May 2024 4 more
    Cipla promoter group sells 2.53% stake to generate liquidity
    Business Today | 15 May 2024
    Cipla Shares Gain After Promoters Sell 2.5% Stake
    NDTV Profit | 15 May 2024
    Cipla Promoters Plan Stake Sale For Rs 2,638 Crore
    NDTV Profit | 14 May 2024
    Cipla promoters to sell up to 2.5% stake for 2637 crore
    Business Line | 14 May 2024
    logo
    Mankind Pharma Ltd.
    15 May 2024
    2471.40
    -0.11%
    Mankind Pharma Q4 Results: Profit Rises 62.3%, Beats Estimates
    Mankind Pharma Q4 Results: Profit Rises 62.3%, Beats Estimates
    NDTV Profit
    The pharma company's net profit rose 62.3% year-on-year to Rs 477 crore in the January-March quarter.
    Copy LinkShare onShare on Share on Share on
    Mankind Pharma Ltd. is trading below all available SMAs
    logo
    Granules India Ltd.
    15 May 2024
    High Gain High Volume
    492.25
    5.35%
    Granules India Q4 Results: Profit Rises 8%, Misses Estimates
    Granules India Q4 Results: Profit Rises 8%, Misses Estimates
    NDTV Profit
    Net profit grew 8% to Rs 130 crore in the quarter ended March, compared with Rs 120 crore in the year-ago period.
    Copy LinkShare onShare on Share on Share on
    Granules India Ltd. is trading at high volume of 16.9M with price gain of 5.35.
    logo
    Acutaas Chemicals Ltd.
    14 May 2024
    1406.00
    0.29%
    Ami Organics Q4 Results Review - Improved Performance Led By Volumes: IDBI Capital
    Ami Organics Q4 Results Review - Improved Performance Led By Volumes: IDBI Capital
    NDTV Profit
    Ramp up of Fermion orders and further orders wins from leading pharma customers/innovators will be strong growth catalysts for the core pharma intermediates business.
    Copy LinkShare onShare on Share on Share on
    Acutaas Chemicals Ltd. has gained 103.61% in the last 1 Year
    logo
    Piramal Pharma Ltd.
    14 May 2024
    183.44
    -1.54%
    Piramal Pharma Q4 Results Review - Solid Quarter; Grim Near-Term Outlook: ICICI Securities
    Piramal Pharma Q4 Results Review - Solid Quarter; Grim Near-Term Outlook: ICICI Securities
    NDTV Profit
    Contract development manufacturing organisation outlook intact, investment in complex hospital generics business on rise
    Copy LinkShare onShare on Share on Share on
    Piramal Pharma Ltd. is trading below all available SMAs
    logo
    Piramal Pharma Ltd.
    14 May 2024
    183.44
    -1.54%
    In 3-5 years, Piramal Pharma can see 22- 25% EBITDA growth margins: Nandini Piramal
    In 3-5 years, Piramal Pharma can see 22- 25% EBITDA growth margins: Nandini Piramal
    Economic Times
    Nandini Piramal projects early teens revenue growth for FY25 and 22-25% EBITDA growth margins in 3-5 years. Revenue increase drives margin expansion through cost optimization and operational excellence, with a focus on CDMO and Indian consumer products growth.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 257 to 247 in Jun 2025 qtr
    logo
    Piramal Pharma Ltd.
    13 May 2024
    183.44
    -1.54%
    On-patent and differentiated offerings will give Piramal Pharma an edge, says Chairperson
    Business Line
    The strategy is to stay the course and grow CDM and consumer healthcare businesses
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 257 to 247 in Jun 2025 qtr
    Piramal Pharma Shares At 52-Week High After Profit Doubles
    NDTV Profit | 13 May 2024
    logo
    Cipla Ltd.
    13 May 2024
    1589.40
    0.58%
    Broker's call: Cipla (Buy)
    Business Line
    Choice Equity
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 1114 to 1124 in Jun 2025 qtr.
    Cipla shares surge over 6% post Q4 results. Should you buy or sell?
    Economic Times | 13 May 2024 2 more
    Cipla Shares Surge As Q4 Profit Beats Estimates
    NDTV Profit | 13 May 2024
    Cipla Q4 Results Review - Strong All-Round Performance: Nirmal Bang
    NDTV Profit | 13 May 2024
    logo
    Neuland Laboratories Ltd.
    13 May 2024
    13455.00
    2.59%
    Neuland Labs Shares Tumble Nearly 15% After Profit Declines 20% In Q4
    Neuland Labs Shares Tumble Nearly 15% After Profit Declines 20% In Q4
    NDTV Profit
    The company reported a consolidate net profit of Rs 67.6 crore during the January-March quarter, compared with Rs 84.5 crore a year ago, beating Bloomberg estimated of Rs 24.4 crore.
    Copy LinkShare onShare on Share on Share on
    Neuland Laboratories Ltd. is trading below its 30 day SMA of 13484.8
    logo
    Piramal Pharma Ltd.
    10 May 2024
    183.44
    -1.54%
    Piramal Pharma Q4 Results: Profit Rises, But Misses Estimates
    Piramal Pharma Q4 Results: Profit Rises, But Misses Estimates
    NDTV Profit
    Net profit of the company rose two times YoY to Rs 101.27 crore in the fourth quarter, as compared with Rs 50.11 crore in the year-ago period.
    Copy LinkShare onShare on Share on Share on
    Piramal Pharma Ltd. is trading below all available SMAs
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd